Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Chris Lange | Jul 30, 2018 at 10:40 AM EDT

What to Expect When Pfizer Reports Tuesday

Pfizer is scheduled to release its second-quarter financial results before the markets open on Tuesday.

Chris Lange | Jul 30, 2018 at 10:05 AM EDT

Why Sienna Biopharmaceuticals Shares Are Stumbling

Sienna Biopharmaceuticals shares pulled back on Monday after the company announced less than favorable results from a couple of its…

Chris Lange | Jul 30, 2018 at 9:50 AM EDT

Why RedHill Is Monday’s Big Biopharma Winner

RedHill Biopharma shares made a solid gain early on Monday after the firm announced positive results from its late-stage trial…

Chris Lange | Jul 27, 2018 at 11:20 AM EDT

Why AbbVie Earnings Were Not Enough for Investors

AbbVie released a better-than-expected quarterly report early on Friday, but shares retreated afterward.

Chris Lange | Jul 27, 2018 at 10:40 AM EDT

Merck Underwhelms Despite Beating Earnings

Merck reported better-than-expected second-quarter results before the markets opened on Friday, but shares retreated afterward.

Chris Lange | Jul 26, 2018 at 10:40 AM EDT

Should Celgene Be Getting More Love?

Celgene released better-than-expected quarterly results and updated guidance before the markets opened on Thursday.

Chris Lange | Jul 25, 2018 at 4:19 PM EDT

Gilead Earnings Beat Not Enough For Investors

Gilead reported its most recent quarterly results after the markets closed on Wednesday. The major biotech posted $1.91 in earnings…

Chris Lange | Jul 25, 2018 at 12:40 PM EDT

What to Expect When Gilead Reports

Gilead is scheduled to release its second-quarter financial results after the markets close on Wednesday, and analyst expectations are low.

Chris Lange | Jul 25, 2018 at 7:35 AM EDT

Major Pharma Stocks Scare Off Short Sellers

The July 13 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Jul 25, 2018 at 7:10 AM EDT

Major Biotechs See a Rising Tide of Short Interest

The July 13 short interest data have been compared with the previous report, and short interest in most of the…

Chris Lange | Jul 24, 2018 at 10:55 AM EDT

Does Biogen Deserve More Credit for Q2 Earnings?

Biogen released better-than-expected second-quarter financial results before the markets opened on Tuesday.

Chris Lange | Jul 23, 2018 at 1:45 PM EDT

Why Haliburton Is Monday’s Big Earnings Loser

Haliburton released solid second-quarter financial results before the markets opened on Monday, but there are growing concerns.

Chris Lange | Jul 23, 2018 at 11:05 AM EDT

Reata Pharmaceuticals Wins Big in Kidney Study

Reata shares saw a solid gain on Monday after the company reported results from a couple midstage kidney trials.

Chris Lange | Jul 23, 2018 at 10:20 AM EDT

Why LifePoint Is Surging

LifePoint Health shares made a solid gain on to start off the week after it was announced that the private…

Chris Lange | Jul 22, 2018 at 10:25 AM EDT

Amgen, Eli Lilly, Gilead and More Major Health Care Companies Reporting This Week

24/7 Wall St. has put together a preview of AbbVie, Eli Lilly, Gilead Sciences and some of the other, larger…

1 … 124 125 126 127 128 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

What to Expect When Pfizer Reports Tuesday

Why Sienna Biopharmaceuticals Shares Are Stumbling

Why RedHill Is Monday’s Big Biopharma Winner

Why AbbVie Earnings Were Not Enough for Investors

Merck Underwhelms Despite Beating Earnings

Should Celgene Be Getting More Love?

Gilead Earnings Beat Not Enough For Investors

What to Expect When Gilead Reports

Major Pharma Stocks Scare Off Short Sellers

Major Biotechs See a Rising Tide of Short Interest

Does Biogen Deserve More Credit for Q2 Earnings?

Why Haliburton Is Monday’s Big Earnings Loser

Reata Pharmaceuticals Wins Big in Kidney Study

Why LifePoint Is Surging

Amgen, Eli Lilly, Gilead and More Major Health Care Companies Reporting This Week

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Health and Healthcare Articles

All Health and Healthcare Articles

What to Expect When Pfizer Reports Tuesday

Why Sienna Biopharmaceuticals Shares Are Stumbling

Why RedHill Is Monday’s Big Biopharma Winner

Why AbbVie Earnings Were Not Enough for Investors

Merck Underwhelms Despite Beating Earnings

Should Celgene Be Getting More Love?

Gilead Earnings Beat Not Enough For Investors

What to Expect When Gilead Reports

Major Pharma Stocks Scare Off Short Sellers

Major Biotechs See a Rising Tide of Short Interest

Does Biogen Deserve More Credit for Q2 Earnings?

Why Haliburton Is Monday’s Big Earnings Loser

Reata Pharmaceuticals Wins Big in Kidney Study

Why LifePoint Is Surging

Amgen, Eli Lilly, Gilead and More Major Health Care Companies Reporting This Week

Wealthy, Rich, or Upper Class? The retirement numbers at every tier

Bernstein Analyst: AI Agents Drive Chip Demand ‘Off the Charts,’ Supply Can’t Keep Up

Eli Lilly Captures 60% of the GLP-1 Market as Mounjaro Revenue Soars 125%

Featured Reads

A Couple With $3.1 Million Disagrees on Whether to Take Social Security at 62 or 70

This health insurer lost 2 million customers — and made $1.5 Billion anyway. Here's how